Skip to content
Bills from the 2021–22 session

Assembly Bill 181

Newborn screening for Krabbe disease and requiring evaluation of additional lysosomal storage disorders for mandatory screening. (FE)

Stopped before the full Assembly voted

The recommended passing it, but the full Assembly never voted on it. To try again, a lawmaker would have to start a new bill.

  1. Introduced, passed

    Mar 23, 2021

  2. Committee, passed

    Approved

  3. Assembly vote, stopped here

    Stopped here. The full Assembly never voted on it.

  4. Senate vote, not reached

  5. Governor, not reached

  6. Law, not reached

Latest entry in the official record, Mar 15, 2022: “Failed to pass pursuant to ⁠”

Read the bill

Following saves it on this device. New actions show on your Following page. You can also get updates in a feed reader.

What it would have done

Summary by the , the Legislature's nonpartisan drafting office. It's their wording, not ours.

This bill requires that, in addition to the other congenital and metabolic disorders for which testing is currently required under rules established by the Department of Health Services, the attending physician, nurse-midwife, or in certain circumstances, other birth attendant, must ensure that every infant born undergoes testing for globoid cell leukodystrophy, also known as Krabbe disease, which is a lysosomal storage disorder. Current law requires that an attending physician or nurse-midwife ensure that every infant born undergoes testing for certain congenital and metabolic disorders prior to the infant's discharge from the hospital or maternity home. For infants born elsewhere, the attending physician, nurse-midwife, or other birth attendant must ensure that the infant is tested within a week of birth. As authorized by current law, DHS specifies by rule the congenital and metabolic disorders for which newborn infants are to be screened. Current law allows an exception to the testing requirement if the parents or legal guardian object on the basis of a conflict with religious tenets and practices or with their personal convictions.

Under the bill, for infants born in a hospital or maternity home, the attending physician or nurse-midwife must ensure testing for Krabbe disease is completed before the infant is discharged or within one week of birth, if the infant has not yet been discharged. For births occurring outside a hospital or maternity home setting, the attending physician, nurse-midwife, or other birth attendant must ensure testing is done within one week of birth. The parental objection exemption under current law also applies to the testing required under this bill.

Read the full summary

The bill also requires DHS to evaluate on a biennial basis the appropriateness of mandatory newborn testing for lysosomal storage disorders in addition to the testing for Krabbe disease. If DHS determines that testing for one or more other lysosomal storage disorders is appropriate, DHS may promulgate rules adding to the list of disorders for which newborn testing is required.

Who's behind it

11 representatives are its ⁠. All 11 are Republicans.

6 more lawmakers ⁠.

See all 17 names

Authors (11)

Signed on in support (6)

What it would cost

State agencies filed a . Each opens as a PDF from the Legislature.

Versions and amendments

Every text the Legislature printed for this bill, including proposed changes. Each opens on the Legislature's site.

How lawmakers voted

There were 2 votes on this bill.

Assembly Committee on Health vote on an amendment

Passed, 15 to 0 · Feb 1, 2022

No member-by-member record exists for this vote. Committee votes and some older sessions record totals only.

Official motion: “Report Assembly Amendment 2 adoption recommended by Committee on Health, Ayes 15, Noes 0”. Official record · This vote on its own page

Assembly Committee on Health vote to recommend it

Passed, 9 to 6 · Feb 1, 2022

No member-by-member record exists for this vote. Committee votes and some older sessions record totals only.

Official motion: “Report passage as amended recommended by Committee on Health, Ayes 9, Noes 6”. Official record · This vote on its own page

What happened

  1. Mar 15, 2022

    The session ended, and the bill died with it.

  2. Feb 1, 2022

    Sent to the Assembly Committee on Rules.

  3. Feb 1, 2022

    The committee voted to recommend passing it, 9 to 6.

  4. Jul 29, 2021

    The committee held a public hearing.

  5. Apr 29, 2021

    1 more senator signed on in support.

  6. Apr 26, 2021

    A state agency sent in its estimate of the cost.

  7. Mar 23, 2021

    Sent to the Assembly Committee on Health.

  8. Mar 23, 2021

    Introduced in the Assembly.

See the official record, word for word
  1. Mar 23, 2021 · Assembly

    Introduced by Representatives Novak, Tranel, Dittrich, Kitchens, Rozar, Shankland, Skowronski, Spiros, Swearingen, Tauchen, Tusler, Vorpagel and Subeck; cosponsored by Senators Testin, Marklein, Darling, L. Taylor and Bernier

  2. Mar 23, 2021 · Assembly

    Read first time and referred to Committee on Health

  3. Apr 26, 2021 · Assembly

    Fiscal estimate received

  4. Apr 29, 2021 · Assembly

    Senator Roys added as a cosponsor

  5. Jun 8, 2021 · Assembly

    Assembly Amendment 1 offered by Representative Novak

  6. Jul 29, 2021 · Assembly

    Public hearing held

  7. Oct 13, 2021 · Assembly

    Assembly Amendment 2 offered by Representative Novak

  8. Jan 11, 2022 · Assembly

    Representative Subeck withdrawn as a coauthor

  9. Jan 12, 2022 · Assembly

    Representative Shankland withdrawn as a coauthor

  10. Jan 12, 2022 · Assembly

    Executive action taken

  11. Feb 1, 2022 · Assembly

    Report Assembly Amendment 2 adoption recommended by Committee on Health, Ayes 15, Noes 0

  12. Feb 1, 2022 · Assembly

    Report passage as amended recommended by Committee on Health, Ayes 9, Noes 6

  13. Feb 1, 2022 · Assembly

    Referred to committee on Rules

  14. Mar 15, 2022 · Assembly

    Failed to pass pursuant to Senate Joint Resolution 1

Terms on this page

Committee

A small group of lawmakers that looks at a bill first. Most bills never leave committee.

More in the glossary

Senate Joint Resolution 1

The session's calendar. Any bill not passed by its last voting day dies.

Official term: Failed to pass pursuant to SJR 1. More in the glossary

Legislative Reference Bureau

The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.

Official term: LRB analysis. More in the glossary

Author

A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.

Official term: Author, coauthor. More in the glossary

Signed on in support

Lawmakers who back a bill without being one of its authors, often from the other chamber.

Official term: Cosponsor. More in the glossary

Cost estimate

A state agency's estimate of what a bill would cost or save.

Official term: Fiscal estimate. More in the glossary

Roll call

A vote where each lawmaker's yes or no is recorded by name.

Official term: Roll call vote. More in the glossary

From the Wisconsin Legislature's official record, checked Sep 15, 2026. See the source

Committee

A small group of lawmakers that looks at a bill first. Most bills never leave committee.

Senate Joint Resolution 1

The session's calendar. Any bill not passed by its last voting day dies.

Official term: Failed to pass pursuant to SJR 1

Legislative Reference Bureau

The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.

Official term: LRB analysis

Author

A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.

Official term: Author, coauthor

Signed on in support

Lawmakers who back a bill without being one of its authors, often from the other chamber.

Official term: Cosponsor

Cost estimate

A state agency's estimate of what a bill would cost or save.

Official term: Fiscal estimate

Roll call

A vote where each lawmaker's yes or no is recorded by name.

Official term: Roll call vote